Have you been diagnosed with non-small cell lung cancer? Have you already been treated with an anti PDL-1 therapy and chemotherapy? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of the investigational drug RMC-6236 to docetaxel.

We are looking for adults ages 18 and up who are interested in using digital tools, a smartphone app, and text messages to help them make positive changes in their eating, activity, and weight.

We're looking into whether a dietary supplement from fish oils can ease ongoing jaw and face pain. These oils have ingredients that help calm inflammation and aid healing. By comparing this supplement to a placebo, which is just an inactive oil, we aim to see if the supplement can relieve chronic jaw pain and learn how it affects the body.

We're exploring how students use AI tools, like ChatGPT, to help with schoolwork and how colleges are responding. We want to know how these tools help students, especially those that are first in their family to attend college, in subjects like science and math. We'll collect information from schools on the kinds of rules they are putting in place. This way, we can understand better how AI is helping students and how colleges can support everyone fairly.

The purpose is to see if a drug, remibrutinib 25 mg twice a day, is safe and effective in treatment of peanut, milk or egg allergy.

We're looking at two alcohol sensors you can wear, the BACtrack Skyn and ArborSense. We want to know how easy and comfortable these are for you to use every day. Your feedback will help us decide which device is better for future studies.

Early puberty can bring social, emotional, and mental health challenges. We want to learn more about parents' concerns and experiences so we can provide better support for families in the future. Parents or caregivers of girls ages 9-14 years old who experienced early puberty are invited to participate in focus groups to share their thoughts and experiences about their daughter's early puberty. Compensation provided.

Are you a transgender or nonbinary young adult, ages 18-25, living in North Carolina? You may be eligible to take part in a research study exploring the experiences of TGNB young adults with gender-affirming care, including both the challenges and supports along the way. Participation involves a brief survey and an online interview (about 1.5-2 hours total). The interview will be scheduled at your convenience and conducted via Zoom. Compensation: $60 gift card

The purpose of this study is to compare the usual treatment alone (chemoradiation and pembrolizumab followed by pembrolizumab) to using induction chemotherapy therapy with pembrolizumab before chemoradiation and pembrolizumab followed by pembrolizumab. The addition of providing induction therapy (carboplatin, paclitaxel, and pembrolizumab) prior to the usual chemoradiation and pembrolizumab therapy could shrink your cancer or prevent it from returning

Do you take charge of your health by going to check-ups or screenings? If you're a Black adult, you could join a study focused on experiences with preventive care. We want to hear how you interact with doctors, what obstacles you face in getting health information, and what helps or hinders your health care. Your insights will help researchers understand the health decisions Black adults make, aiming to improve the healthcare experience for others in your community.